StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.66+0.07 (+4.40%)

Close on Nov 20, 2026Market cap $4.22MP/E –Yield –

Alaunos Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Alaunos Therapeutics's pe ratio was 0.1× on Jan 31, 2025, against 4.3× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20250.1×−0.0
2024Dec 31, 20240.2×−5.5
2020Jan 31, 20205.7×−1.1
2019Dec 31, 20196.8×–

More Alaunos Therapeutics figures

See a number that looks wrong?